Intended for healthcare professionals


Low risk prostate cancer: active surveillance does not increase unfavourable outcomes, study finds

BMJ 2024; 385 doi: (Published 03 June 2024) Cite this as: BMJ 2024;385:q1213
  1. Janice Hopkins Tanne
  1. New York

Active surveillance of men with prostate cancer with a low risk of metastasis is an appropriate alternative to immediate surgery or radiation, a long term, prospective, multicentre study of 2155 men has found.1

The Canary Prostate Active Surveillance (Pass) study was conducted at 10 North American medical centres, with findings reported in JAMA. It found that 10 years after diagnosis disease had not progressed in almost half (49%) of the men. Fewer than 2% of the men developed metastatic disease, and fewer than 1% died from prostate cancer.

“The rates of unfavorable outcomes—including adverse pathology at surgical procedure, recurrence after treatment, or metastasis—do not …

View Full Text

Log in

Log in through your institution


* For online subscription